Literature DB >> 15685248

beta1-Adrenoceptor gene polymorphism predicts long-term changes in body weight.

Y Linné1, I Dahlman, J Hoffstedt.   

Abstract

BACKGROUND: The genes controlling long-term weight changes are largely unknown. The beta1 (beta1)-adrenoceptor gene contains two nonsynonomous single nucleotide polymorphisms (SNPs), Ser49Gly and Gly389Arg, that both are functional in human cell lines.
DESIGN: We investigated the influence of these two SNPs on short- and long-term changes in body mass index (BMI) in a population-based cohort of 761 women who were examined during pregnancy in 1984-1985 and 15 y thereafter.
RESULTS: At entry, no genotype effect on BMI was found. After 15 y, the BMI of women carrying the Gly49-genotype (25.3+/-0.3 kg/m(2)) was higher (P<0.005) than that of Ser49-women (24.4+/-0.2 kg/m(2)). Also, the BMI-increase over 15 y was higher (P=0.018) in Gly49-women (3.3+/-0.2 kg/m(2)) than in Ser49-women (2.8+/-0.1 kg/m(2)). The odds ratio for being overweight after 15 y having the Gly49-genotype was 1.6 (confidence interval 1.1-2.3, P=0.01). No effect of SNP 389 alone on BMI was found but there was a genotype-genotype interaction. Those carrying the Gly49-Gly389 combination increased their BMI about 0.7 kg/m(2) more than other combinations (P=0.025). No genotype effect on BMI changes during pregnancy for either SNP was found.
CONCLUSION: Polymorphism of the beta1-adrenoceptor gene influences long-term weight gain and the incidence of adult-onset overweight in women.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15685248     DOI: 10.1038/sj.ijo.0802892

Source DB:  PubMed          Journal:  Int J Obes (Lond)        ISSN: 0307-0565            Impact factor:   5.095


  9 in total

Review 1.  {beta}-Adrenoceptor gene variation and intermediate physiological traits: prediction of distant phenotype.

Authors:  John H Eisenach; Erica D Wittwer
Journal:  Exp Physiol       Date:  2010-04-09       Impact factor: 2.969

2.  A common β1-adrenergic receptor polymorphism predicts favorable response to rate-control therapy in atrial fibrillation.

Authors:  Babar Parvez; Nagesh Chopra; Shane Rowan; Joseph C Vaglio; Raafia Muhammad; Dan M Roden; Dawood Darbar
Journal:  J Am Coll Cardiol       Date:  2012-01-03       Impact factor: 24.094

3.  Roles of beta2- and beta3-adrenoceptor polymorphisms in hypertension and metabolic syndrome.

Authors:  Kazuko Masuo
Journal:  Int J Hypertens       Date:  2010-10-21       Impact factor: 2.420

4.  ADRB3 polymorphism rs4994 (Trp64Arg) associates significantly with bodyweight elevation and dyslipidaemias in Saudis but not rs1801253 (Arg389Gly) polymorphism in ARDB1.

Authors:  Maha Daghestani; Mazin Daghestani; Mamoon Daghistani; Abdelmoneim Eldali; Zeinab K Hassan; Maha H Elamin; Arjumand Warsy
Journal:  Lipids Health Dis       Date:  2018-03-27       Impact factor: 3.876

5.  Association analyses of adrenergic receptor polymorphisms with obesity and metabolic alterations.

Authors:  John J Lima; Hua Feng; Laurie Duckworth; Jianwei Wang; James E Sylvester; Niranjan Kissoon; Hardesh Garg
Journal:  Metabolism       Date:  2007-06       Impact factor: 8.694

6.  Using linkage analysis to identify quantitative trait loci for sleep apnea in relationship to body mass index.

Authors:  E K Larkin; S R Patel; R C Elston; C Gray-McGuire; X Zhu; S Redline
Journal:  Ann Hum Genet       Date:  2008-08-26       Impact factor: 1.670

7.  Relationships of adrenoceptor polymorphisms with obesity.

Authors:  Kazuko Masuo; Gavin W Lambert
Journal:  J Obes       Date:  2011-04-04

8.  Genome wide association study identifies KCNMA1 contributing to human obesity.

Authors:  Hong Jiao; Peter Arner; Johan Hoffstedt; David Brodin; Beatrice Dubern; Sébastien Czernichow; Ferdinand van't Hooft; Tomas Axelsson; Oluf Pedersen; Torben Hansen; Thorkild I A Sørensen; Johannes Hebebrand; Juha Kere; Karin Dahlman-Wright; Anders Hamsten; Karine Clement; Ingrid Dahlman
Journal:  BMC Med Genomics       Date:  2011-06-28       Impact factor: 3.063

9.  Vitamin D Supplementation and Genetic Polymorphisms Impact on Weight Loss Diet Outcomes in Caucasians: A Randomized Double-Blind Placebo-Controlled Clinical Study.

Authors:  Konstantinos Xenos; Maria Papasavva; Athanasios Raptis; Martha-Spyridoula Katsarou; Nikolaos Drakoulis
Journal:  Front Med (Lausanne)       Date:  2022-03-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.